Elia Borbas brings over 29 years of experience in Clinical Operations in the biotechnology and pharmaceutical industry. She has broad experience in all phases of clinical development from early clinical through successful NDA and BLA filings and has also led successful regulatory agency inspections. Her expertise reaches across multiple therapeutic areas including Hematology/Oncology, Cardiac, Pulmonary, Endocrine, Renal, Pain Management and CNS.
Ms. Borbas has served as Executive Director of Clinical Operations at Jazz Pharmaceuticals where she was responsible for the strategy and management of several global clinical programs. She has held management positions at SurroMed, Inc., and consulted at Bristol Myers Squibb, Genentech and Chiron. She attended University of Michigan and earned a B.S. in Nursing at Catholic University of America. She is the CEO of her own consulting company working with Bay Area biotech startups and midsize to large pharmaceutical companies.